CDK4 and liposarcoma: The most evidence, to date, demonstrates an oncogenic role in dedifferentiated liposarcoma, like the atypical lipomatous tumor/well-differentiated liposarcoma, for MDM2, CDK4, HMGA2, and TSPAN31 (SAS) (55, 64, 70, 71, 84).